Nanamiya, R.; Saito-Koyama, R.; Miki, Y.; Inoue, C.; Asavasupreechar, T.; Abe, J.; Sato, I.; Sasano, H.
EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of Osimertinib on Cell Cycle Progression in Non-Small Cell Lung Cancer. Int. J. Mol. Sci. 2021, 22, 8522.
https://doi.org/10.3390/ijms22168522
AMA Style
Nanamiya R, Saito-Koyama R, Miki Y, Inoue C, Asavasupreechar T, Abe J, Sato I, Sasano H.
EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of Osimertinib on Cell Cycle Progression in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 2021; 22(16):8522.
https://doi.org/10.3390/ijms22168522
Chicago/Turabian Style
Nanamiya, Ren, Ryoko Saito-Koyama, Yasuhiro Miki, Chihiro Inoue, Teeranut Asavasupreechar, Jiro Abe, Ikuro Sato, and Hironobu Sasano.
2021. "EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of Osimertinib on Cell Cycle Progression in Non-Small Cell Lung Cancer" International Journal of Molecular Sciences 22, no. 16: 8522.
https://doi.org/10.3390/ijms22168522
APA Style
Nanamiya, R., Saito-Koyama, R., Miki, Y., Inoue, C., Asavasupreechar, T., Abe, J., Sato, I., & Sasano, H.
(2021). EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of Osimertinib on Cell Cycle Progression in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences, 22(16), 8522.
https://doi.org/10.3390/ijms22168522
